Benedetta Cambò

Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia After Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey

Corrado Girmenia, Alice Bertaina, Alfonso Piciocchi et al. · Clinical Infectious Diseases · 2017 · 160 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy

Irene Gañán‐Gómez, Hui Yang, Feiyang Ma et al. · Nature Medicine · 2022 · 81 citations · Full text

Medicine, Hematology, Pharmacology +17

Nelarabine as salvage therapy and bridge to allogeneic stem cell transplant in 118 adult patients with relapsed/refractory T‐cell acute lymphoblastic leukemia/lymphoma. A CAMPUS ALL study

Anna Candoni, Davide Lazzarotto, Felicetto Ferrara et al. · American Journal of Hematology · 2020 · 70 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Venetoclax and Bortezomib in Relapsed/Refractory Early T-Cell Precursor Acute Lymphoblastic Leukemia

Roberta La Starza, Benedetta Cambò, Antonio Pierini et al. · JCO Precision Oncology · 2019 · 44 citations · Full text

Medicine, Oncology, Pharmacology +9

The -2518 A/G polymorphism of the monocyte chemoattractant protein-1 as a candidate genetic predisposition factor for secondary myelofibrosis and biomarker of disease severity

Elena Masselli, Cecilia Carubbi, Benedetta Cambò et al. · Leukemia · 2018 · 18 citations · Full text

Life Sciences, Genetics, Molecular Genetics +15